Table 1

Baseline demographic characteristics of each cohort

N = 251/group

Group A (RA)

Group B (DM)

Group C (GP)

P; All three

P; A versus C


Age

Years (SD)

48.5 (10.0)

49.1 (9.8)

49.0 (9.3)

0.8


Gender

Male

47 (19%)

47 (19%)

47 (19%)

1

Female

204 (81%)

204 (81%)

204 (81%)


Race

Caucasian

203 (81%)

203 (81%)

203 (81%)

African-American

27 (11%)

27 (11%)

27 (11%)

Asian

17 (7%)

17 (7%)

17 (7%)

Other

4 (< 2%)

4 (< 2%)

4 (< 2%)


Disease duration

Years (SD)

10.0 (8.4)

9.3 (9.0)

N/A

0.08

N/A


Personal history

HTN

71 (28%)

130 (52%)

71 (28%)

< 0.0001

1

HL

55 (22%)

114 (45%)

48 (19%)

< 0.0001

0.5

CAD

5 (2%)

27 (11%)

6 (2%)

< 0.0001

1

MI

5 (2%)

12 (5%)

2 (1%)

.01

0.4

CVA

4 (2%)

14 (6%)

4 (2%)

.009

1


Family history

CAD

74 (30%)

95 (38%)

62 (25%)

0.005

0.3

MI

30 (12%)

49 (20%)

28 (11%)

0.012

0.9

CVA

35 (14%)

25 (10%)

25 (10%)

0.3

0.2


CRP

0.9

N/A

N/A


Hemoglobin A1c

N/A

7.5

N/A


CAD, coronary artery disease; CRP, C-reactive protein; CVA, cerebrovascular accident; DM, diabetes mellitus; GP, general population; HL, hyperlipidemia; HTN, hypertension; MI, myocardial infarction; N/A, not applicable; RA, rheumatoid arthritis.

Desai et al. Arthritis Research & Therapy 2012 14:R270   doi:10.1186/ar4118

Open Data